<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33682641</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.</ArticleTitle><Pagination><StartPage>619</StartPage><EndPage>628</EndPage><MedlinePgn>619-628</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/22221751.2021.1899772</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) inactivated vaccines have been widely inoculated among children in Kunming City after it was approved. However, there was a large-scale outbreak of Enteroviruses (EVs) infection in Kunming, 2018. The epidemiological characteristics of HFMD and EVs were analysed during 2008-2018, which are before and three years after EV-A71 vaccine starting to use. The changes in infection spectrum were also investigated, especially for severe HFMD in 2018. The incidence of EV-A71 decreased dramatically after the EV-A71 vaccine starting use. The proportion of non-CV-A16/EV-A71 EVs positive patients raised to 77.17-85.82%, while, EV-A71 and CV-A16 only accounted for 3.41-7.24% and 6.94-19.42% in 2017 and 2018, respectively. CV-A6 was the most important causative agent in all clinical symptoms (severe HFMD, HFMD, Herpangina and fever), accounting from 42.13% to 62.33%. EV-A71 only account for 0.36-2.05%. In severe HFMD, CV-A6 (62.33%), CV-A10 (11.64%), and CV-A16 (10.96%) were the major causative agent in 2018. EV-A71 inactivated vaccine has a good protective effect against EV-A71 and induced EVs infection spectrum changefully. EV-A71 vaccine has no or insignificant cross-protection effect on CV-A6, CV-A10, and CV-A16. Herein, developing 4-valent combined vaccines is urgently needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hongchao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaodan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Diseases, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meifen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Tingyi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jiaolian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Shuying</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Diseases, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Diseases, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Diseases, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Junying</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Diseases, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Mao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tiesong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kunming Children's Hospital, The Affiliated Children's Hospital of Kunming Medical University; Institute of Pediatric Disease Research in Yunnan, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Children's Major Disease Research, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qiangming</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Diseases, Kunming, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015164">Vaccines, Inactivated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015164" MajorTopicYN="N">Vaccines, Inactivated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hand-foot-and-mouth disease</Keyword><Keyword MajorTopicYN="N">enterovirus A71 vaccine</Keyword><Keyword MajorTopicYN="N">epidemiological characteristics</Keyword><Keyword MajorTopicYN="N">pathogen spectrum</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>8</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33682641</ArticleId><ArticleId IdType="pmc">PMC8018479</ArticleId><ArticleId IdType="doi">10.1080/22221751.2021.1899772</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, et al. . The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16:368&#x2013;381. doi:10.1038/s41579-018-0005-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, et al. . Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014;14:308&#x2013;318. doi:10.1016/S1473-3099(13)70342-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, et al. . Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10:778&#x2013;790. doi:10.1016/s1473-3099(10)70194-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Min N, Sakthi Vale PD, Wong AA, et al. . Circulating salivary miRNA hsa-miR-221 as clinically validated diagnostic marker for hand, foot, and mouth disease in pediatric patients. EBioMedicine. 2018;31:299&#x2013;206. doi:10.1016/j.ebiom.2018.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2018.05.006</ArticleId><ArticleId IdType="pmc">PMC6014581</ArticleId><ArticleId IdType="pubmed">29754884</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H, Duan G, Zhang R, et al. . Time series analysis of hand-foot-mouth disease hospitalization in Zhengzhou: establishment of forecasting models using climate variables as predictors. PloS One. 2014;9:e87916. doi:10.1371/journal.pone.0087916</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087916</ArticleId><ArticleId IdType="pmc">PMC3909295</ArticleId><ArticleId IdType="pubmed">24498221</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee BY, Wateska AR, Bailey RR, et al. . Forecasting the economic value of an enterovirus 71 (EV71) vaccine. Vaccine. 2010;28:7731&#x2013;7736. doi:10.1016/j.vaccine.2010.09.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.09.065</ArticleId><ArticleId IdType="pmc">PMC2989421</ArticleId><ArticleId IdType="pubmed">20923711</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi S, Liao Q, Van Boeckel TP, et al. . Hand, foot, and mouth disease in China: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination. PLoS Med. 2016;13:e1001958. doi:10.1371/journal.pmed.1001958</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001958</ArticleId><ArticleId IdType="pmc">PMC4755668</ArticleId><ArticleId IdType="pubmed">26882540</ArticleId></ArticleIdList></Reference><Reference><Citation>Mclntyre MG, Stevens KM, Davidson S.. Notes from the field: severe hand, foot, and mouth disease associated with coxsackievirus A6 &#x2013; Alabama, Connecticut, California, and Nevada, November 2011&#x2013;February 2012. MMWR Morbidity and Mort Wkly Rep. 2012;61:213&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">22456122</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Yuan J, Wang X, et al. . Severe hand, foot, and mouth disease and coxsackievirus A6-shenzhen, China. Clin Infect Dis. 2014;59:1504&#x2013;1505. doi:10.1093/cid/ciu624</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu624</ArticleId><ArticleId IdType="pubmed">25091307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayman R, Shepherd M, Tarring C, et al. . Outbreak of variant hand-foot-and-mouth disease caused by coxsackievirus A6 in Auckland, New Zealand. J Paediatr Child Health. 2014;50(10):751&#x2013;755. doi:10.1111/jpc.12708</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpc.12708</ArticleId><ArticleId IdType="pubmed">25123330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair C, Gaunt E, Simmonds P, et al. . Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. Euro Surveill. 2014;19:20745. es2014. 19.12.20745. doi:10.2807/1560-7917</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917</ArticleId><ArticleId IdType="pubmed">24698138</ArticleId></ArticleIdList></Reference><Reference><Citation>Owino CO, Chu JJH.. Recent advances on the role of host factors during non-poliovirus enteroviral infections. J Biomed Sci. 2019;26:47. doi:10.1186/s12929-019-0540-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0540-y</ArticleId><ArticleId IdType="pmc">PMC6582496</ArticleId><ArticleId IdType="pubmed">31215493</ArticleId></ArticleIdList></Reference><Reference><Citation>Iturriza-G&#xf3;mara M, Megson B, Gray J.. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. J Med Virol. 2006;78:243&#x2013;253. doi:10.1002/jmv.20533</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20533</ArticleId><ArticleId IdType="pubmed">16372287</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S, Klemola P, Kaijalainen S, et al. . Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol. 2010;48:49&#x2013;54. doi:10.1016/j.jcv.2010.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.02.002</ArticleId><ArticleId IdType="pubmed">20189452</ArticleId></ArticleIdList></Reference><Reference><Citation>Henquell C, Archimbaud C, Ughetto S, et al. . Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect. 2012;18:E110&#x2013;E118. doi:10.1111/j.1469-0691.2012.03789.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2012.03789.x</ArticleId><ArticleId IdType="pubmed">22404077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu QB, Zhang XA, Wo Y, et al. . Circulation of coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011. PLoS One. 2012;7:e52073. doi:10.1371/journal.pone.0052073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052073</ArticleId><ArticleId IdType="pmc">PMC3525556</ArticleId><ArticleId IdType="pubmed">23272213</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, Ding J, Cao J, et al. . Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10. J Med Virol. 2015;87:954&#x2013;960. doi:10.1371/journal.pone.0052073</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052073</ArticleId><ArticleId IdType="pubmed">25754274</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, He S, Yan Q, et al. . Severe hand, foot and mouth disease associated with coxsackievirus A10 infections in Xiamen, China in 2015. J Clin Virol. 2017;93:20&#x2013;24. doi:10.1016/j.jcv.2017.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2017.05.011</ArticleId><ArticleId IdType="pubmed">28577423</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsop J, Flewett TH, Foster JR.. &#x201c;Hand-foot-and-mouth disease&#x201d; in Birmingham in 1959. Br Med J. 1960;2:1708&#x2013;1711. doi:10.1136/bmj.2.5214.1708</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.2.5214.1708</ArticleId><ArticleId IdType="pmc">PMC2098292</ArticleId><ArticleId IdType="pubmed">13682692</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, et al. . Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, Malaysia: clinical and pathological characteristics of the disease. For the outbreak study group. Clin Infect Dis. 2000;31:678&#x2013;683. doi:10.1086/314032</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, et al. . An epidemic of enterovirus 71 infection in Taiwan. Taiwan enterovirus epidemic working group. N Engl J Med. 1999;341:929&#x2013;935. doi:10.1056/NEJM199909233411301</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KP, Goh KT, Chong CY, et al. . Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerging Infect Dis.. 2003;9:78&#x2013;85. doi:10.3201/eid0901.020112</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0901.020112</ArticleId><ArticleId IdType="pmc">PMC2873753</ArticleId><ArticleId IdType="pubmed">12533285</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji TJ, Han TL, Tan XJ, et al. . Surveillance, epidemiology, and pathogen spectrum of hand, foot, and mouth disease in mainland of China from 2008 to 2017. Biosaf Health. 2019;1:32&#x2013;40. doi:10.1016/j.bsheal.2019.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsheal.2019.02.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JP, Baden L, Pallansch MA, et al. . Enterovirus 71 infections and neurologic disease&#x2013;United States, 1977-1991. J Infect Dis. 1994;169:905&#x2013;908. doi:10.1093/infdis/169.4.905</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/169.4.905</ArticleId><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan D, van der Sanden S, Zeng H, et al. . Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010. PLoS One. 2012;7:e44386. doi:10.1371/journal.pone.0044386</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044386</ArticleId><ArticleId IdType="pmc">PMC3440427</ArticleId><ArticleId IdType="pubmed">22984501</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Zou G, Liao Q, et al. . Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples. Clin Infect Dis. 2018;67:1729&#x2013;1735. doi:10.1093/cid/ciy341</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy341</ArticleId><ArticleId IdType="pubmed">29688329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Shao J, et al. . The compatibility of inactivated-enterovirus 71 vaccination with coxsackievirus A16 and poliovirus immunizations in humans and animals. Hum Vaccin Immunother. 2015;11:2723&#x2013;2733. doi:10.1080/21645515.2015.1011975</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2015.1011975</ArticleId><ArticleId IdType="pmc">PMC4685687</ArticleId><ArticleId IdType="pubmed">25715318</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, An D, Liu W, et al. . Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay. PLoS One. 2014;9:e100545. doi:10.1371/journal.pone.0100545</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0100545</ArticleId><ArticleId IdType="pmc">PMC4070950</ArticleId><ArticleId IdType="pubmed">24964084</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S, Arunkumar G, Alidjinou EK, et al. . Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med Microbiol Immunol. 2016;205:397&#x2013;307. doi:10.1007/s00430-016-0465-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>